Endoscopic gastric cancer screening and surveillance in high-risk groups

Clinical Endoscopy

Volumn 47, Issue 6, 2014, Pages 497-503

  Choi, Il Ju ^a  

^a National Cancer Center   (South Korea)

Author keywords

Endoscopy; Screening; Stomach neoplasms; Surveillance

Indexed keywords

EID: 84912119368     PISSN: 22342400     EISSN: 22342443     Source Type: Journal    
DOI: 10.5946/ce.2014.47.6.497     Document Type: Article

References (66)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. Epub 2014 Sep 13. DOI: http://dx.doi.org/10.1002/ijc.29210.
2. Jung K W, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-123.
3. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-3560.
4. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23: 351-365.
5. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Heli-cobacter pylori infection: the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-664.
6. Herrero R, Parsonnet J, Greenberg ER. Prevention of gastric cancer. JAMA 2014;312:1197-1198.
7. Lee KS, Oh DK, Han MA, et al. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat 2011;43:83-88.
8. Hamashima C, Shibuya D, Yamazaki H, et al. Te Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008;38:259-267.
9. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer 2013;132:1272-1276.
10. Dan Y Y, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 2006;4:709-716.
11. Hassan C, Quintero E, Dumonceau JM, et al. Post-polypectomy colo-noscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013;45:842-851.
12. Zhou HJ, Dan YY, Naidoo N, Li SC, Yeoh KG. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk. PLoS One 2013;8:e83959.
13. Gotoda T, Ishikawa H, Ohnishi H, et al. Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with se-rology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy. Gastric Cancer. Epub 2014 Aug 13. DOI: http://dx.doi.org/10.1007/s10120-014-0408-5.
14. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008;9:279-287.
15. Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precan-cerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94.
16. Bae JM. Methodological issues for determining intervals of subsequent cancer screening. Epidemiol Health 2014;36:e2014010.
17. Bae JM, Shin SY, Kim EH. Mean sojourn time of preclinical gastric cancer in Korean men: a retrospective observational study. J Prev Med Public Health 2014;47:201-205.
18. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hofmeis-ter M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol 2011;174:1140-1146.
19. Kwak H W, Choi IJ, Cho SJ, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol 2014;29:1671-1677.
20. Park CH, Kim EH, Chung H, et al. Te optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc 2014;80:253-259.
21. Nam JH, Choi IJ, Cho SJ, et al. Association of the interval between en-doscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer 2012;118:4953-4960.
22. Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fu-kao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One 2013;8:e79088.
23. Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer 2010;102:237-242.
24. Han MA, Oh MG, Choi IJ, et al. Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol 2012;30:701-708.
25. Pedrazzani C, Corso G, Velho S, et al. Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer 2009; 8:215-220.
26. Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer 2012;12:8.
27. Deng N, Goh LK, Wang H, et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012; 61:673-684.
28. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513:202-209.
29. Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010;47:436-444.
30. Kluijt I, Sijmons RH, Hoogerbrugge N, et al. Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer 2012;11:363-369.
31. Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 2010;13:1-10.
32. Corso G, Roncalli F, Marrelli D, Carneiro F, Roviello F. History, patho-genesis, and management of familial gastric cancer: original study of John XXIII’s family. Biomed Res Int 2013;2013:385132.
33. Chinese Society of Gastroenterology, Chinese Study Group on Helico-bacter pylori, Liu WZ, Xie Y, . Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2013;14:211-221.
34. Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol 2014;29:1371-1386.
35. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helico-bacter 2010;15:1-20.
36. Rugge M, Correa P, Dixon M F, et al. Gastric mucosal atrophy: interob-server consistency using new criteria for classification and grading. Aliment Pharmacol Ter 2002;16:1249-1259.
37. Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83:253-260.
38. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its signifcance in chronic gastritis. Endoscopy 1969;1:87-97.
39. Dixon M F, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181.
40. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-658.
41. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71:1150-1158.
42. Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ter 2010;31:1104-1111.
43. Cho SJ, Choi IJ, Kook MC, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ter 2013;38:1292-1302.
44. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-768.
45. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter 2010;15:486-490.
46. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-340.
47. Chung SJ, Park MJ, Kang SJ, et al. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer 2012; 131:2376-2384.
48. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-123.
49. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma afer endoscop-ic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-397.
50. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mu-cosal resection. Endoscopy 2005;37:990-993.
51. Jang M Y, Cho J W, Oh WG, et al. Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection. Korean J Intern Med 2013;28:687-693.
52. Kato M, Nishida T, Yamamoto K, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 2013;62:1425-1432.
53. Nakajima T, Oda I, Gotoda T, et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer 2006;9:93-98.
54. Kim YI, Choi IJ, Kook MC, et al. Te association between Helicobacter pylori status and incidence of metachronous gastric cancer after endo-scopic resection of early gastric cancer. Helicobacter 2014;19:194-201.
55. Choi IJ, Lee JH, Kim YI, et al. Long-term outcome comparison of en-doscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. Epub 2014 Sep 30. DOI: http://dx.doi.org/10.1016/j.gie.2014.07.047.
56. Choi J, Kim SG, Yoon H, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 2014;12: 793-800.
57. Bae SE, Jung H Y, Kang J, et al. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol 2014;109:60-67.
58. Maehata Y, Nakamura S, Fujisawa K, et al. Long-term effect of Helico-bacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012;75:39-46.
59. Eom B W, Lee JH, Choi IJ, et al. Pretreatment risk factors for multiple gastric cancer and missed lesions. J Surg Oncol 2012;105:813-817.
60. Lee HL, Eun CS, Lee OY, et al. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc 2010;71:1159-1165.
61. Lee J Y, Choi IJ, Cho SJ, et al. Routine follow-up biopsies after complete endoscopic resection for early gastric cancer may be unnecessary. J Gastric Cancer 2012;12:88-98.
62. Kobayashi M, Narisawa R, Sato Y, Takeuchi M, Aoyagi Y. Self-limiting risk of metachronous gastric cancers afer endoscopic resection. Dig Endosc 2010;22:169-173.
63. Ahn HS, Kim J W, Yoo M W, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol 2008;15:1632-1639.
64. Park JH, Lee JH, Rhee PL, et al. Endoscopic screening for remnant gastric cancer: points to be considered. Gut Liver 2007;1:22-26.
65. Lee J Y, Choi IJ, Cho SJ, et al. Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc 2010;24:1360-1366.
66. Nonaka S, Oda I, Makazu M, et al. Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy. Gas-trointest Endosc 2013;78:63-72.